Literature DB >> 4373721

Adenylate cyclase from Brevibacterium liquefaciens. III. In situ regulation of adenylate cyclase by pyruvate.

K Umezawa, K Takai, S Tsuji, Y Kurashina, O Hayaishi.   

Abstract

In the presence of DL-alanine intracellular cyclic AMP in nonproliferating cells of Brevibacterium liquefaciens increased rapidly to the maximum level of approximately 180 muM, and extracellular cyclic AMP increased to 100 muM within 4 hr at 25 degrees . Adenylate cyclase (EC 4.6.1.1) induction was not observed during this incubation. The concentration of pyruvate in the total culture increased concomitantly with that of cyclic AMP and reached approximately 20 mM after 4 hr of incubation. Since the activity of cyclic nucleotide phosphodiesterase is extremely low in this bacterium, the accumulation of cyclic AMP with DL-alanine appeared to be due to the activation of adenylate cyclase by pyruvate. D-alanine was more effective than L-alanine in producing pyruvate, and a high activity of D-alanine oxidation was detected in the cell lysate of B. liquefaciens.Thus, adenylate cyclase in this bacterium appeared to be regulated in vivo by pyruvate which was formed, in this case, predominantly from D-alanine through the action of D-aminoacid oxidase (EC 1.4.3.3). Pyruvate, added extracellularly, also caused a rapid accumulation of intracellular cyclic AMP. Glucose did not change the level of cyclic AMP significantly. It also did not affect the intracellular accumulation of cyclic AMP with DL-alanine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373721      PMCID: PMC433935          DOI: 10.1073/pnas.71.11.4598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  ADENOSINE 3',5'-PHOSPHATE IN ESCHERICHIA COLI.

Authors:  R S MAKMAN; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  Excretion of adenosine-3',5'-phosphate in the culture broth of Brevibacterium liquefaciens.

Authors:  T OKABAYASHI; M IDE; A YOSHIMOTO
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

3.  Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme.

Authors:  P E Stanley; S G Williams
Journal:  Anal Biochem       Date:  1969-06       Impact factor: 3.365

4.  Adenyl cyclase of Brevibacterium liquefaciens.

Authors:  M Hirata; O Hayaishi
Journal:  Biochim Biophys Acta       Date:  1967-11-21

5.  Adenylate cyclase from Brevibacterium liquefaciens. I. Purification, crystallization, and some properties.

Authors:  K Takai; Y Kurashina; C Suzuki-Hori; H Okamoto; O Hayaishi
Journal:  J Biol Chem       Date:  1974-03-25       Impact factor: 5.157

6.  Formation of adenosine cyclic 3',5'-phosphate by nonproliferating cells and cell-free extract of Brevibacterium liquefaciens.

Authors:  M Ide; A Yoshimoto; T Okabayashi
Journal:  J Bacteriol       Date:  1967-08       Impact factor: 3.490

7.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

8.  Glucose and the metabolism of adenosine 3':5'-cyclic monophosphate in Escherichia coli.

Authors:  A Peterkofsky; C Gazdar
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

9.  OCCURRENCE OF NUCLEOTIDES IN CULTURE FLUIDS OF MICROORGANISMS. V. EXCRETION OF ADENOSINE CYCLIC 3',5'-PHOSPHATE BY BREVIBACTERIUM LIQUEFACIENS SP. N.

Authors:  T OKABAYASHI; A YOSHIMOTO; M IDE
Journal:  J Bacteriol       Date:  1963-11       Impact factor: 3.490

  9 in total
  2 in total

1.  Brevibacterium liquefaciens adenylate cyclase and its in vivo stimulation by pyruvate.

Authors:  T J Lynch; E A Tallant; W Y Cheung
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

2.  Regulation of cyclic AMP levels in Arthrobacter crystallopoietes and a morphogenetic mutant.

Authors:  R W Hamilton; P E Kolenbrander
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.